ALKS insider trading
Open-market stock trades by Alkermes (ALKS) executives and directors: who bought or sold, how many shares, at what price and when.
ALKS insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $41.03 | $83.46K |
| Sep 3, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $48.01 | $97.65K |
| Sep 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $46.99 | $422.87K |
| Aug 17, 2026 | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,912 | $49.19 | $339.97K |
| Aug 17, 2026 | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 664 | $49.65 | $32.97K |
| Aug 3, 2026 | snyderman nancy lynn MD | director | Sell | 44,472 | $50.35 | $2.24M |
| Aug 3, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $48.58 | $437.22K |
| Aug 3, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $48.58 | $98.81K |
| Jul 6, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $54.03 | $109.90K |
| Jul 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 8,300 | $51.46 | $427.13K |
| Jul 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 700 | $52.13 | $36.49K |
| Jun 12, 2026 | Wright Christopher I | director | Sell | 2,000 | $45.10 | $90.20K |
| Jun 4, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $43.05 | $87.56K |
| Jun 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $41.67 | $375.04K |
| May 29, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 16,217 | $42.36 | $687.01K |
| May 4, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $33.20 | $67.53K |
| May 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $33.40 | $300.56K |
| Apr 6, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $34.57 | $70.32K |
| Apr 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $35.51 | $319.60K |
| Mar 2, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 6,890 | $29.29 | $201.81K |
| Mar 2, 2026 | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,000 | $30.00 | $180.00K |
- ALKS insiders bought $0.00 and sold $6.71M in open-market trades over their last 21 filings.
Updated 2026-11-03 00:03 UTC